Bausch + Lomb, the global eye health company, and ISTA Pharmaceuticals, Inc. , today announced that they have signed a definitive agreement under which Bausch + Lomb will acquire ISTA for $9.10 per share in cash, or a total of approximately $500 million.
Bausch + Lomb to acquire ISTA Pharmaceuticals